Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis-Reference-Cited by-同舟云学术

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Published:2022-01 Issue:1 Volume:20 Page:126-135
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Lukin Dana,Faleck David,Xu Ronghui,Zhang Yiran,Weiss Aaron,Aniwan Satimai,Kadire Siri,Tran Gloria,Rahal Mahmoud,Winters Adam,Chablaney Shreya,Koliani-Pace Jenna L.,Meserve Joseph,Campbell James P.,Kochhar Gursimran,Bohm Matthew,Varma Sashidhar,Fischer Monika,Boland Brigid,Singh Siddharth,Hirten Robert,Ungaro Ryan,Lasch Karen,Shmidt Eugenia,Jairath Vipul,Hudesman David,Chang Shannon,Swaminath Arun,Shen Bo,Kane Sunanda,Loftus Edward V.,Sands Bruce E.,Colombel Jean-Frederic,Siegel Corey A.,Sandborn William J.,Dulai Parambir S.^ORCID

Funder

Takeda Pharmaceuticals North America

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis;Mao;Aliment Pharmacol Ther,2017

2. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus;Bressler;Gastroenterology,2015

3. ACG clinical guideline: ulcerative colitis in adults;Rubin;Am J Gastroenterol,2019

4. Third European evidence-based consensus on diagnosis and management of ulcerative colitis: part 2—current management;Harbord;J Crohns Colitis,2017

5. American Gastroenterological Association Institute clinical guideline on the management of moderate to severe ulcerative colitis;Feuerstein;Gastroenterology,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of metagenome and metabolome disclosed the mechanisms of Dendrobium officinale polysaccharide on DSS-induced ulcerative colitis-affected mice;International Journal of Biological Macromolecules;2024-10

2. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

3. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología;2024-08

4. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología (English Edition);2024-08

5. Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers;American Journal of Gastroenterology;2024-07-12